<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Symptom Advice .com &#187; investment advice</title>
	<atom:link href="http://symptomadvice.com/tag/investment-advice/feed/" rel="self" type="application/rss+xml" />
	<link>http://symptomadvice.com</link>
	<description></description>
	<lastBuildDate>Tue, 29 May 2012 22:17:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Hemispherx Biopharma shares rise on FDA extension of new drug application</title>
		<link>http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/</link>
		<comments>http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 07:34:13 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[fatigue symptoms]]></category>
		<category><![CDATA[disclosure]]></category>
		<category><![CDATA[investment advice]]></category>
		<category><![CDATA[investment strategy]]></category>
		<category><![CDATA[regard]]></category>
		<category><![CDATA[suitability]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/</guid>
		<description><![CDATA[No investment advice The Company &#105;&#115; a publisher and &#105;&#115; not registered &#119;&#105;&#116;&#104; &#111;&#114; authorised by the Financial Services Authority (FSA). &#121;&#111;&#117; understand and agree that &#110;&#111; content published on the Site constitutes a recommendation that &#097;&#110;&#121; particular security, portfolio &#111;&#102; securities, transaction, &#111;&#114; investment strategy &#105;&#115; suitable &#111;&#114; advisable for &#097;&#110;&#121; specific person. &#121;&#111;&#117; [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="" style="float:left;clear:both;margin:0 15px 15px 0" />No investment advice
<p>The Company &#105;&#115; a publisher and &#105;&#115; not registered &#119;&#105;&#116;&#104; &#111;&#114; authorised by the Financial Services Authority (FSA). &#121;&#111;&#117; understand and agree that &#110;&#111; content published on the Site constitutes a recommendation that &#097;&#110;&#121; particular security, portfolio &#111;&#102; securities, transaction, &#111;&#114; investment strategy &#105;&#115; suitable &#111;&#114; advisable for &#097;&#110;&#121; specific person. &#121;&#111;&#117; &#102;&#117;&#114;&#116;&#104;&#101;&#114; understand that &#110;&#111;&#110;&#101; &#111;&#102; the information providers &#111;&#114; their affiliates &#119;&#105;&#108;&#108; advise &#121;&#111;&#117; personally &#099;&#111;&#110;&#099;&#101;&#114;&#110;&#105;&#110;&#103; the nature, potential, advisability, value &#111;&#114; suitability &#111;&#102; &#097;&#110;&#121; particular security, portfolio &#111;&#102; securities, transaction, investment strategy, &#111;&#114; other matter.</p>
<p>You understand that the Site &#109;&#097;&#121; &#099;&#111;&#110;&#116;&#097;&#105;&#110; opinions &#102;&#114;&#111;&#109; time &#116;&#111; time &#119;&#105;&#116;&#104; regard &#116;&#111; securities mentioned in other products, including company related products, and that those opinions &#109;&#097;&#121; be different &#102;&#114;&#111;&#109; those obtained by using another product related &#116;&#111; the Company. &#121;&#111;&#117; understand and agree that contributors &#109;&#097;&#121; write &#097;&#098;&#111;&#117;&#116; securities in &#119;&#104;&#105;&#099;&#104; &#116;&#104;&#101;&#121; &#111;&#114; their firms have a position, and that &#116;&#104;&#101;&#121; &#109;&#097;&#121; trade such securities for their &#111;&#119;&#110; account. In cases where the position &#105;&#115; held at the time &#111;&#102; publication and such position &#105;&#115; &#107;&#110;&#111;&#119;&#110; &#116;&#111; the Company, appropriate disclosure &#105;&#115; made. &#104;&#111;&#119;&#101;&#118;&#101;&#114;, &#121;&#111;&#117; understand and agree that at the time &#111;&#102; &#097;&#110;&#121; transaction that &#121;&#111;&#117; make, &#111;&#110;&#101; &#111;&#114; more contributors &#109;&#097;&#121; have a position in the securities written &#097;&#098;&#111;&#117;&#116;. &#121;&#111;&#117; understand that price and other data &#105;&#115; supplied by sources believed &#116;&#111; be reliable, that the calculations &#104;&#101;&#114;&#101;&#105;&#110; are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers &#111;&#114; &#097;&#110;&#121; other person &#111;&#114; entity, and &#109;&#097;&#121; not be complete &#111;&#114; accurate.</p>
<p>From time &#116;&#111; time, reference &#109;&#097;&#121; be made in &#111;&#117;&#114; marketing materials &#116;&#111; prior articles and opinions we have published. These references &#109;&#097;&#121; be selective, &#109;&#097;&#121; reference &#111;&#110;&#108;&#121; a portion &#111;&#102; an article &#111;&#114; recommendation, and are likely not &#116;&#111; be current. As markets change continuously, previously published information and data &#109;&#097;&#121; not be current and &#115;&#104;&#111;&#117;&#108;&#100; not be relied upon.</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/hemispherx-biopharma-shares-rise-on-fda-extension-of-new-drug-application/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Online Stock Trading Investing Day Trading</title>
		<link>http://symptomadvice.com/online-stock-trading-investing-day-trading/</link>
		<comments>http://symptomadvice.com/online-stock-trading-investing-day-trading/#comments</comments>
		<pubDate>Mon, 06 Dec 2010 07:17:09 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[throat symptoms]]></category>
		<category><![CDATA[future returns]]></category>
		<category><![CDATA[investment advice]]></category>
		<category><![CDATA[investment advisory service]]></category>
		<category><![CDATA[investment results]]></category>
		<category><![CDATA[trading securities]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/online-stock-trading-investing-day-trading/</guid>
		<description><![CDATA[Disclaimer: The Connors Group, Inc. (&#8220;Company&#8221;) &#105;&#115; not an investment advisory service, &#110;&#111;&#114; &#097; registered investment advisor &#111;&#114; broker-dealer and does not purport &#116;&#111; tell &#111;&#114; suggest which securities &#111;&#114; currencies customers &#115;&#104;&#111;&#117;&#108;&#100; buy &#111;&#114; sell for themselves. The analysts and employees &#111;&#114; affiliates of Company &#109;&#097;&#121; hold positions in the stocks, currencies &#111;&#114; industries [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2010/12/1291619829-85.png%3Fw%3D505%26h%3D288" style="clear:both;clear:both;margin:0 15px 15px 0;width:500px" />Disclaimer:
<p>The Connors Group, Inc. (&#8220;Company&#8221;) &#105;&#115; not an investment advisory service, &#110;&#111;&#114; &#097; registered investment advisor &#111;&#114; broker-dealer and does not purport &#116;&#111; tell &#111;&#114; suggest which securities &#111;&#114; currencies customers &#115;&#104;&#111;&#117;&#108;&#100; buy &#111;&#114; sell for themselves. The analysts and employees &#111;&#114; affiliates of Company &#109;&#097;&#121; hold positions in the stocks, currencies &#111;&#114; industries discussed here. You understand and acknowledge that &#116;&#104;&#101;&#114;&#101; &#105;&#115; &#097; very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility &#111;&#114; liability for &#121;&#111;&#117;&#114; trading and investment results. Factual statements on the Company&#8217;s website, &#111;&#114; in its publications, are made &#097;&#115; of the date stated and are subject &#116;&#111; change &#119;&#105;&#116;&#104;&#111;&#117;&#116; notice.</p>
<p>It &#115;&#104;&#111;&#117;&#108;&#100; not &#098;&#101; assumed that the methods, techniques, &#111;&#114; indicators presented in &#116;&#104;&#101;&#115;&#101; products will &#098;&#101; profitable &#111;&#114; that they will not result in losses. &#112;&#097;&#115;&#116; results of &#097;&#110;&#121; individual trader &#111;&#114; trading system published by Company are not indicative of future returns by that trader &#111;&#114; system, and are not indicative of future returns which &#098;&#101; realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company&#8217;s products (collectively, the &#8220;Information&#8221;) are &#112;&#114;&#111;&#118;&#105;&#100;&#101;&#100; for informational and educational purposes &#111;&#110;&#108;&#121; and &#115;&#104;&#111;&#117;&#108;&#100; not &#098;&#101; construed &#097;&#115; investment advice. Examples presented on Company&#8217;s website are for educational purposes &#111;&#110;&#108;&#121;. Such set-ups are not solicitations of &#097;&#110;&#121; order &#116;&#111; buy &#111;&#114; sell. &#097;&#099;&#099;&#111;&#114;&#100;&#105;&#110;&#103;&#108;&#121;, you &#115;&#104;&#111;&#117;&#108;&#100; not rely solely on the Information in making &#097;&#110;&#121; investment. Rather, you &#115;&#104;&#111;&#117;&#108;&#100; &#117;&#115;&#101; the Information &#111;&#110;&#108;&#121; &#097;&#115; &#097; starting point for doing additional independent research in order &#116;&#111; &#097;&#108;&#108;&#111;&#119; you &#116;&#111; form &#121;&#111;&#117;&#114; &#111;&#119;&#110; opinion regarding investments. You &#115;&#104;&#111;&#117;&#108;&#100; &#097;&#108;&#119;&#097;&#121;&#115; check with &#121;&#111;&#117;&#114; licensed financial advisor and tax advisor &#116;&#111; determine the suitability of &#097;&#110;&#121; investment.</p>
<p>HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.</p>
<p>The Connors Group, Inc. 10 Exchange &#112;&#108;&#097;&#099;&#101;, Suite 1800 Jersey City, NJ 07302 </p>
<p>&copy; Copyright 2010 The Connors Group, Inc.</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/online-stock-trading-investing-day-trading/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
